InnovAge (INNV) director granted 8,539 RSUs vesting in 2027

Rhea-AI Filing Summary

Bush John Ellis reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. director John Ellis Bush received an equity award of 8,539 Restricted Stock Units (RSUs), which will be settled in common shares. The RSUs vest in full on June 30, 2027, subject to his continued service. Following this grant, he directly holds 53,696 shares reported on this Form 4. This is a compensation-related award at no cash purchase price, not an open-market stock buy.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bush John Ellis

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.001 par value	8,539	$0.00	--

Holdings After Transaction: Common Stock, $0.001 par value — 53,696 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 8,539 units Grant price: $0.00 per unit Post-grant holdings: 53,696 shares +1 more

4 metrics

RSU grant size 8,539 units Restricted Stock Units granted to director John Ellis Bush

Grant price $0.00 per unit RSU award recorded with zero purchase price

Post-grant holdings 53,696 shares Total common shares directly held after the transaction

Vesting date June 30, 2027 RSUs vest in full on this date, subject to continued service

Key Terms

Restricted Stock Units ("RSUs"), vest in full, grant/award acquisition

3 terms

Restricted Stock Units ("RSUs") financial

"Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"and will vest in full on June 30, 2027, subject to the Reporting Person's continued service"

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:32 PM Accepted by SEC EDGAR 07/02/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bush John Ellis

(Last) (First) (Middle)

8950 E LOWRY BLVD

(Street)

DENVER COLORADO 80230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	07/01/2026		A		8,539(1)	A	$0	53,696	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Remarks:

	/s/ Nicole D'Amato, by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did InnovAge (INNV) report for John Ellis Bush?

InnovAge reported that director John Ellis Bush received an equity award of 8,539 Restricted Stock Units (RSUs). These units are a form of stock-based compensation, not an open-market purchase, and will convert into common shares once they fully vest in 2027.

How many InnovAge shares are involved in John Ellis Bush’s RSU grant?

The grant covers 8,539 Restricted Stock Units, each intended to settle in one share of InnovAge common stock. These RSUs vest in full on June 30, 2027, assuming Bush continues serving the company through that date as specified.

When do John Ellis Bush’s InnovAge RSUs vest according to the Form 4?

The RSUs granted to John Ellis Bush vest in full on June 30, 2027. Vesting is conditioned on his continued service with InnovAge through that date, meaning the award becomes deliverable as common stock only after that vesting milestone is reached.

Did John Ellis Bush buy InnovAge (INNV) shares on the open market?

No, the Form 4 shows a grant of 8,539 Restricted Stock Units at a price of $0.00 per unit. This indicates a compensation-related award from InnovAge, rather than an open-market stock purchase funded with his own cash.

What is John Ellis Bush’s InnovAge share position after this RSU award?

After the RSU grant, John Ellis Bush is reported as directly holding 53,696 shares of InnovAge common stock. This figure reflects his total direct holdings following the award, giving context for the scale of the compensation-related equity grant.